Stocks
GlaxoSmithKline (GSK) EV/EBITDA US GAAP (year values) |
|||||||||
| 2022 | 2022 | 2022 | 2023 | 2023 | LTM ? | CAGR 5 years ? | |||
| EV/EBITDA | ? | 9.52 | 9.75 | 17.6 | 17.6 | 18.1 | 8.59 | ||
| Changes by years, y/y, % | -18% | +2% | +80% | 0% | +3% | +6.5% | |||
GlaxoSmithKline. EV/EBITDA
GlaxoSmithKline. EV/EBITDA, changes, %
GlaxoSmithKline (GSK) EV/EBITDA US GAAP (quarter values) |
||||||||
| 2024Q2 | 2024Q1 | 2024Q3 | 2024Q2 | 2024Q3 | LTM ? | |||
| EV/EBITDA | ? | 9.52 | 10.4 | 8.07 | 17.2 | 10.1 | 8.59 | |
| Changes by years, y/y, % | -44% | -44% | -4% | +2% | +19% | |||
| Changes by quarters, q/q, % | -41% | +9% | -22% | +113% | -42% | |||
